Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.205 SGD | +19.88% |
|
0.00% | -2.38% |
24/04 | Abundante Limited Reports Earnings Results for the Full Year Ended February 29, 2024 | CI |
2023 | Abundante Liquidates Dormant Unit | MT |
Valuation
Fiscal Period: February | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capitalization 1 | 13.92 | 7.307 | 9.743 | 14.5 | 14.6 | 21.9 |
Enterprise Value (EV) 1 | 10.63 | 2.405 | 4.172 | 1.079 | 0.5902 | 8.786 |
P/E ratio | -2.94 x | -4.17 x | -7.36 x | 5.13 x | 17.6 x | 19.2 x |
Yield | - | - | - | 7.19% | - | - |
Capitalization / Revenue | 1.55 x | 0.8 x | 1.94 x | 1.76 x | 1.86 x | 2.75 x |
EV / Revenue | 1.18 x | 0.26 x | 0.83 x | 0.13 x | 0.08 x | 1.1 x |
EV / EBITDA | 9.19 x | 2.66 x | -10.7 x | 0.79 x | 0.51 x | 6.96 x |
EV / FCF | 6.91 x | 1.8 x | 4.68 x | 1.85 x | 0.48 x | -4.29 x |
FCF Yield | 14.5% | 55.5% | 21.4% | 54.1% | 209% | -23.3% |
Price to Book | 1.06 x | 0.64 x | 0.97 x | 0.82 x | 0.84 x | 1.19 x |
Nbr of stocks (in thousands) | 69,591 | 69,591 | 69,591 | 1,04,291 | 1,04,291 | 1,04,291 |
Reference price 2 | 0.2000 | 0.1050 | 0.1400 | 0.1390 | 0.1400 | 0.2100 |
Announcement Date | 06/06/19 | 06/08/20 | 08/06/21 | 06/06/22 | 07/06/23 | 03/06/24 |
Income Statement Evolution (Annual data)
Fiscal Period: February | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales 1 | 8.981 | 9.091 | 5.011 | 8.237 | 7.838 | 7.972 |
EBITDA 1 | 1.157 | 0.9037 | -0.39 | 1.366 | 1.161 | 1.262 |
EBIT 1 | -2.175 | -0.689 | -1.459 | 1.139 | 0.4516 | 0.595 |
Operating Margin | -24.22% | -7.58% | -29.12% | 13.83% | 5.76% | 7.46% |
Earnings before Tax (EBT) 1 | -4.219 | -2.143 | -1.416 | 2.589 | 0.791 | 1.189 |
Net income 1 | -4.74 | -1.754 | -1.324 | 2.444 | 0.8296 | 1.143 |
Net margin | -52.77% | -19.29% | -26.42% | 29.67% | 10.58% | 14.34% |
EPS 2 | -0.0681 | -0.0252 | -0.0190 | 0.0271 | 0.007954 | 0.0110 |
Free Cash Flow 1 | 1.538 | 1.334 | 0.8908 | 0.5833 | 1.231 | -2.047 |
FCF margin | 17.12% | 14.67% | 17.78% | 7.08% | 15.71% | -25.68% |
FCF Conversion (EBITDA) | 132.89% | 147.6% | - | 42.71% | 106.08% | - |
FCF Conversion (Net income) | - | - | - | 23.87% | 148.39% | - |
Dividend per Share | - | - | - | 0.0100 | - | - |
Announcement Date | 06/06/19 | 06/08/20 | 08/06/21 | 06/06/22 | 07/06/23 | 03/06/24 |
Balance Sheet Analysis
Fiscal Period: February | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 3.29 | 4.9 | 5.57 | 13.4 | 14 | 13.1 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 1.54 | 1.33 | 0.89 | 0.58 | 1.23 | -2.05 |
ROE (net income / shareholders' equity) | -21.8% | -14.5% | -11.8% | 17.2% | 4.68% | 6.35% |
ROA (Net income/ Total Assets) | -6.44% | -2.82% | -7.09% | 4.51% | 1.47% | 1.94% |
Assets 1 | 73.64 | 62.22 | 18.68 | 54.15 | 56.49 | 58.96 |
Book Value Per Share 2 | 0.1900 | 0.1700 | 0.1400 | 0.1700 | 0.1700 | 0.1800 |
Cash Flow per Share 2 | 0.0500 | 0.0700 | 0.0800 | 0.1300 | 0.0400 | 0.0200 |
Capex 1 | 0.23 | 0.04 | 0.19 | 0.18 | 0.03 | 2.25 |
Capex / Sales | 2.59% | 0.41% | 3.82% | 2.23% | 0.42% | 28.28% |
Announcement Date | 06/06/19 | 06/08/20 | 08/06/21 | 06/06/22 | 07/06/23 | 03/06/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-2.38% | 15.8M | |
+7.14% | 50.71B | |
+3.27% | 37.26B | |
+7.23% | 33.36B | |
+8.43% | 32.74B | |
+17.90% | 20.45B | |
+24.59% | 19.41B | |
+16.85% | 18.66B | |
-13.16% | 9.22B | |
-8.22% | 6.25B |
- Stock Market
- Equities
- 570 Stock
- Financials Abundante Limited